Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates

Core Viewpoint - Select Medical (SEM) reported quarterly earnings of $0.32 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, but down from $0.6 per share a year ago, indicating a mixed performance in earnings [1][2] Financial Performance - The company achieved revenues of $1.34 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.50%, but down from $1.76 billion year-over-year [2] - Over the last four quarters, Select Medical has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Select Medical shares have declined approximately 23.2% since the beginning of the year, contrasting with the S&P 500's gain of 8.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.20 on revenues of $1.32 billion, and for the current fiscal year, it is $1.14 on revenues of $5.37 billion [7] - The trend of estimate revisions for Select Medical was mixed ahead of the earnings release, which may change following the recent report [6] Industry Context - The Medical - HMOs industry, to which Select Medical belongs, is currently ranked in the bottom 5% of over 250 Zacks industries, suggesting potential challenges ahead [8]